Xenetic Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xenetic Biosciences, Inc. on July 15, 2021. The Company is incorporated in Nevada and its common stock (XBIO) and purchase warrants (XBIOW) are registered on The Nasdaq Stock Market LLC.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
On July 15, 2021, Dr. Dmitry Genkin resigned as a member of the Board of Directors. The Company stated that Dr. Genkin's decision to resign was not a result of any disagreement with the Company.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the director resignation.
Key Facts for Investor Verification
- Dr. Dmitry Genkin resigned from the Board of Directors on July 15, 2021.
- The resignation was not caused by any disagreement with the Company.
- The report was signed by James Parslow, Chief Financial Officer, on July 16, 2021.
- No financial performance data is included in this specific filing.